Cardiac resynchronization therapy (CRT) is considered a beneficial and disease-modifying treatment in appropriately selected heart failure (HF) patients. It reduces morbidity and mortality, reverses ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

But new research finds that on extremely hot days, people with the devices face nearly triple the odds for a dangerous ...

Thousands of Americans with heart trouble have small implanted defibrillators, to help regulate their heartbeat and keep ...

The patients' symptoms and clinical status may be correlated with device diagnostics, such as evolution of average heart rates, heart rate variability, and daily activity. Repeated measurement of ...

Severe temperature spikes may double or triple the risk of irregular heart rhythm in people with implanted defibrillators. An analysis of health data for more than 2,000 people with implantable ...

Leadless devices are currently being trialed and may ease implantation and reduce complication rates. Image-guided implantation may improve response in cardiac resynchronization therapy with ...

or cardiac resynchronization therapy defibrillator (CRT-D) implanted between 2016 and 2023. Participants were 71 years old on ...

Medtech EBR has reported a milestone quarter, highlighted by the final submission of its PMA application for the WiSE CRT ...